Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida

被引:23
作者
Light, Michael [2 ]
Bauman, Jay [1 ]
Mavunda, Kunjana [3 ]
Malinoski, Frank [4 ]
Eggleston, Mark [4 ]
机构
[1] Sci & Tech Evalut Pharmaceut Inc, Raleigh, NC USA
[2] Univ Miami, Dept Pediat, Batchelor Childrens Res Inst, Miami, FL 33152 USA
[3] Int Travel Clin, Pediat Pulm Ctr, Miami, FL USA
[4] Medimmune Inc, Dept Med Affairs, Gaithersburg, MD 20878 USA
关键词
respiratory syncytial virus; seasonality; prophylaxis; Florida; hospitalizations;
D O I
10.1097/INF.0b013e318168daf1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Florida experiences year-round outbreaks of respiratory syncytial virus (RSV), but it is unknown if there is a correlation between RSV virology data and disease-related hospitalizations. We analyzed RSV surveillance and hospitalization data for the state of Florida to determine if there is an association between seasonal virology data and the incidence of International Classification of Diseases, 9th revision, clinical modification (ICD-9-CM) coded hospitalizations for RSV lower respiratory tract illness. Methods: We conducted a retrospective analysis for each of 5 regions of Florida for 4 years (2001-2004) of monthly RSV surveillance data presented on the Florida Department of Health web-site and hospitalization data provided by the Agency for Health Care Administration. RSV was considered present when >= 10% of laboratory tests were positive in a given month and the duration of seasons was determined by the number of consecutive months threshold values were exceeded. Hospitalizations in children 24 months of age and younger were defined as RSV related if any of the following RSV-specific ICD-9-CM codes appeared on the discharge summary: 079.6 RSV; 466.11 acute bronchiolitis caused by RSV; and 480.1 pneumonia caused by RSV. Results: RSV circulated year-round statewide and seasons ranged from 7-8 months in the southwest, northwest, and north regions of Florida to 11-12 months in the central and southeast regions, respectively. More than 23,000 children younger than 24 months of age were hospitalized throughout the state for an RSV-related illness during the 4-year period, with almost 20,000 (86%) of the admissions in infants less than 12 months of age. There were 23 hospitalizations yearly per 1000 births and more than 90% of discharges occurred during the defined RSV seasons. Conclusions: To our knowledge, this is the first study to demonstrate a positive correlation between RSV test data and hospitalizations both statewide and for individual regions within Florida. It would be prudent for clinicians to obtain results of local RSV virology data to guide decisions on timing of prophylaxis to prevent RSV hospitalizations.
引用
收藏
页码:512 / 518
页数:7
相关论文
共 50 条
[21]   Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model [J].
Voirin, Nicolas ;
Virlogeux, Victor ;
Demont, Clarisse ;
Kieffer, Alexia .
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) :277-292
[22]   Respiratory Syncytial Virus lower respiratory tract illness in infancy and subsequent morbidity [J].
Sigurs, Nele .
ACTA PAEDIATRICA, 2007, 96 (02) :156-157
[23]   Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea [J].
Yun Hee Baek ;
Eun Hye Choi ;
Min-Suk Song ;
Philippe Noriel Q. Pascua ;
Hyeok-il Kwon ;
Su-Jin Park ;
Jun Han Lee ;
Sung-Il Woo ;
Byung-Hoon Ahn ;
Heon-Seok Han ;
Yoon-Soo Hahn ;
Kyeong-Seob Shin ;
Hae-Lan Jang ;
Seok-Yong Kim ;
Young-Ki Choi .
Archives of Virology, 2012, 157 :1039-1050
[24]   Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives [J].
Law, Amy W. ;
Lin, Jay ;
Judy, Jennifer ;
Pugh, Sarah J. ;
Cane, Alejandro .
VACCINES, 2025, 13 (04)
[25]   Preventative therapies for respiratory Syncytial virus (RSV) in children: Where are we now? [J].
Bourassa, Marie-Helene ;
Lands, Larry C. .
PAEDIATRIC RESPIRATORY REVIEWS, 2024, 49 :24-27
[26]   Costs and benefits of respiratory syncytial virus immunoglobulin to prevent hospitalization for lower respiratory tract illness in very low birth weight infants [J].
O'Shea, TM ;
Sevick, MA ;
Givner, LB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (07) :587-593
[27]   Opportunities for early therapy of respiratory syncytial virus (RSV) infection: what happens before hospitalization [J].
DeVincenzo, JP ;
Aitken, JB ;
Harrison, LG .
ANTIVIRAL RESEARCH, 2004, 62 (01) :47-51
[28]   Respiratory Syncytial Virus (RSV)-Related Hospitalization and Increased Rate of Cardiovascular Events in Older Adults [J].
Verschoor, Chris P. ;
Cerasuolo, Joshua O. ;
Caswell, Joseph M. ;
Tatangelo, Mark ;
Costa-Vitali, Atilio ;
Savage, David W. ;
Kwong, Jeffrey C. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2025,
[29]   Predictors of disease severity are similar for respiratory syncytial virus (RSV)-positive and RSV-negative induced respiratory failure [J].
E Davis ;
K Deem ;
R Mehta ;
M Marsh .
Critical Care, 8 (Suppl 1)
[30]   Phylogeny and population dynamics of respiratory syncytial virus (Rsv) A and B [J].
Martinelli, Marianna ;
Frati, Elena Rosanna ;
Zappa, Alessandra ;
Ebranati, Erika ;
Bianchi, Silvia ;
Pariani, Elena ;
Amendola, Antonella ;
Zehender, Gianguglielmo ;
Tanzi, Elisabetta .
VIRUS RESEARCH, 2014, 189 :293-302